We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Institute of Medicine has issued a report recommending
that dietary supplements be subject to much more stringent rules governing safety
and effectiveness -- much in the same way prescription drugs are regulated.
ChemDiv (Chemical Diversity), a leading provider of discovery chemistry services,
with headquarters located in San Diego, Calif., has entered into a collaborative
agreement with the University of Maryland Greenebaum Cancer Center (UMGCC) in
Baltimore, Md.
Cambrex has announced that its subsidiary Cambrex Bio Science Wokingham has
signed an agreement for the purchase of conditionally immortalized cell lines,
related intellectual property and equipment of Xcellsyz, Newcastle Upon Tyne,
UK. Cambrex Bio Science Walkersville, also a subsidiary of Cambrex, has entered
into license agreements for Geron's proprietary telomerase technology and complementary
conditional immortalization technology from the Ludwig Institute for Cancer
Research (LICR).
Specialty chemical distributor Aceto is making its first major foray into drug
production, through a deal with Three Rivers Pharmaceuticals to bring three
generic products to market.
Addex Pharmaceuticals has entered an exclusive worldwide
research collaboration and license agreement with Ortho-McNeil Pharmaceutical,
a Johnson & Johnson company, to discover, develop and commercialize novel
compounds modulating allosterically G-Protein Coupled Receptors for the treatment
of anxiety, depression, schizophrenia and Alzheimer's disease.